Healthcare workers including pharmacists and nurses should refer patients with hemoglobinopathies to ophthalmologists for assessment of visual function. Even though there are no treatments for early retinopathy caused by these blood disorders, the patients need close monitoring for visual deficits. Newer chelating drugs have been developed and in some cases may prevent worsening of the retinopathy.